Background and aims Systemic lupus erythematosus (SLE) is characterised by hyperactive B cell antigen receptor (BCR) signalling, autoantibody production and glomerulonephritis. Human GWAS studies have shown a strong association between alterations in the Src family kinase Lyn and incidence of SLE. Mice with genetic deletion of Lyn lose peripheral B cell tolerance and display all the hallmark symptoms associated with human SLE. Therefore, Lyn-/- mice represent a clinically relevant model to investigate the molecular regulation of B cell autoimmunity in SLE. We have previously reported that the membrane-cytoskeleton linker protein Ezrin regulates various facets of B cell function through its dynamic phosphorylation and dephosphorylation. Interestingly, we observed that Ezrin is hyperphosphorylated in Lyn-/- B cells, leading to the hypothesis that Ezrin facilitates B cell autoimmunity in Lyn-/- mice.
Methods To test our hypothesis we generated double knockout mice (DKO) bearing systemic deletion of Lyn and conditional deletion of Ezrin in the B cell lineage. B cell activation, lupus-associated autoantibodies and kidney pathology were investigated.
Results Compared to Lyn-deficient mice, the DKO mice displayed reduced germinal centre B cell and plasma cell differentiation, and decrease in autoantibody levels and glomerulonephritis. Further, an increase in BCR repertoire diversity and inhibition of BCR signalling pathways was observed in DKO B cells.
Conclusions Investigation of proteins that drive B cell hyperactivation in SLE is important for the development of effective and novel therapies. Our data demonstrate that ezrin is an important regulator of B cell activation in the absence of Lyn, and thus a potential molecular target in SLE.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.